近期投资事件
更多2017-09-05
选择性口服免疫疗法研发商
医药研发/制造
化学&生物药
IBG Risikokapitalfonds II GmbH & Co. KG;
IBG Risikokapitalfonds II GmbH & Co. KG;
Omega Funds;
Omega Funds;
Bayern Kapital;
LifeCare Partners;
Life Sciences Partners;
Fund+
相关合作机构
最新投融资资讯
更多-
PRNewswire2026-09-16
-
GlobeNewswire2026-09-16
-
PRNewswire2026-09-16
-
PRNewswire2026-09-16
-
PRNewswire2026-09-16
-
Businesswire2026-09-16
-
Businesswire2026-09-16
-
Businesswire2026-09-16
-
PRNewswire2026-09-16
-
PRNewswire2026-09-16